Skip to main content
MedPathMedPath Home
Clinical Trials/NCT06956573
NCT06956573
Not yet recruiting
Not Applicable

Aortic Dimensions in Patients With Fabry Disease

University Hospital, Caen0 sites200 target enrollmentStarted: May 2, 2025Last updated:
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
Not Applicable
Status
Not yet recruiting
Enrollment
200
Primary Endpoint
Maximum ascending aortic diameter measured by transthoracic echocardiography or cardiac MRI, expressed as a Z-score.
OverviewStudy DesignEligibility CriteriaOutcomesInvestigatorsRecords & IdentifiersSimilar Trials

Overview

Brief Summary

We will conduct a retrospective study aiming to define the characteristics, determinants, and progression of ascending aortic dilatation in adults with Fabry disease, using echocardiography and/or cardiac MRI

Study Design

Study Type
Observational
Observational Model
Case Only
Time Perspective
Retrospective

Eligibility Criteria

Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •a adult patients with genetically confirmed Fabry disease must be able to signed informed consent for participation in the study

Exclusion Criteria

  • •Patient refusal to participate in the study

Outcomes

Primary Outcomes

Maximum ascending aortic diameter measured by transthoracic echocardiography or cardiac MRI, expressed as a Z-score.

Time Frame: At baseline

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Fabien LABOMBARDA

MD, PhD

University Hospital, Caen

Similar Trials

Terminated
Not Applicable
Cardiovasculorenal Phenotyping in Fabry Disease Through Noninvasive TestingFabry Disease
NCT05699265Children's Hospital Medical Center, Cincinnati4
Recruiting
Not Applicable
Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular HypertrophyHypertrophic CardiomyopathyLeft Ventricular HypertrophyFabry Disease
NCT06169358Qilu Hospital of Shandong University627
Completed
Not Applicable
Fabry Outcome Survey (FOS)Fabry Disease
NCT03289065Shire4,000
Completed
Not Applicable
A One Visit Follow Up of Adults With Fabry Disease Who Started Long-term Enzyme Replacement Therapy As ChildrenQuality of LifeRenal InsufficiencyCardiac Event
NCT04002531Baylor Research Institute5
Completed
Not Applicable
Autoimmune and Inflammatory Response Biomarkers in Fabry DiseaseFabry Disease
NCT06007768Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal32